Empress Therapeutics co-founders from L-R: John Mendlein, Sabrina Yang, Jason Park, and Doug Cole.

June 21, 2023 06:00 AM EDTUpdated 06:27 AM

Flagship startup Empress Therapeutics launches to search for small molecule drug leads in microbial DNA

Ryan Cross

Senior Science Correspondent

Flagship’s latest startup is betting that a treasure trove of small molecule drugs is waiting to be discovered right inside our bodies — or rather, inside …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Flagship startup Empress Therapeutics launches to search for small molecule drug leads in microbial DNA

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

New fund will pressure flailing biotechs, as investor frustration boils over

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Flag­ship start­up Em­press Ther­a­peu­tics launch­es to search for small mol­e­cule drug leads in mi­cro­bial DNA

Senior Science Correspondent

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Flagship startup Empress Therapeutics launches to search for small molecule drug leads in microbial DNA